Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 2,542 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Hypertension, Cardiovascular Diseases, Sleep Disorder, Arrythmia, Sympathetic Nervous System, Injury Traumatic
Interventions: Not listed
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sleep Apnea, Hypertension
Interventions: Autotitrating Positive Airway Pressure (APAP), Traditional Split Titration Polysomnogram; Device
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Insomnia
Interventions: Solriamfetol 75 MG, Cognitive Behavioral Therapy for Insomnia (CBT-I), Monitoring, Placebo; Drug · Behavioral · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 25 Years to 60 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV/AIDS, Insomnia
Interventions: SHUTi; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS)
Interventions: H-Reflex, Somatosensory evoked potential (SSEP), Vibratory Electrophysiological Response Potential (ERP), Transcranial Magnetic Stimulation (TMS), Spinal Cord Stimulator (SCS) manipulation; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Anxiety, Depression, Insomnia, Sleep Quality
Interventions: Alpha-Stim AID CES (Active Comparator), Alpha-Stim AID CES (Sham Comparator); Device
Lead sponsor: Christina Murphey, RN, PhD; Individual
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Austin, Texas • Corpus Christi, Texas

Conditions: Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Osteoporosis, Circadian Rhythm Sleep Disorder, Shift Work Type
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 50 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: HIV/AIDS, Clinical Depression
Interventions: Zaleplon; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obstructive Sleep Apnea
Interventions: High-resolution pharyngeal manometry catheter; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Burn, Chronic Pain Following Thermal Burn Injury, Non-Pharmacological Interventions, Virtual Reality, Sleep Disturbance, Anxiety, Depressive Symptoms, Fatigue Symptom, Pruritus, Burn Injury, Progressive Muscle Relaxation
Interventions: Virtual Reality-Enhanced Progressive Muscle Relaxation, Standard Progressive Muscle Relaxation; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: REM Behavior Disorder, Parkinson Disease
Interventions: Not listed
Lead sponsor: CND Life Sciences; Other
Eligibility: 50 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 18
States / cities: Scottsdale, Arizona • Irvine, California • Los Angeles, California + 14 more

Conditions: Restless Legs Syndrome
Interventions: Chylobinoid Topical Cream; Drug
Lead sponsor: Synthonics Inc; Industry
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Sarasota, Florida

Conditions: COPD, Insomnia, Cannabis
Interventions: Marijuana; Other
Lead sponsor: National Jewish Health; Other
Eligibility: 21 Years to 80 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Sleep Apnea, Obstructive, Primary Open-angle Glaucoma
Interventions: SENSIMED Triggerfish®; Device
Lead sponsor: Sensimed AG; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstructive Sleep Apnea, Comorbid Insomnia and Sleep Apnea, Insomnia
Interventions: Digital Cognitive Behavioral Therapy (CBT-i)-COAST; Device
Lead sponsor: Thomas Kaffenberger; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obstructive Sleep Apnea, Snoring
Interventions: LinguaFlex Tongue Retractor (LTR); Device
Lead sponsor: Linguaflex, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Brighton, Massachusetts • Morgantown, West Virginia • Milwaukee, Wisconsin

Conditions: Insomnia
Interventions: Lemborexant, Lemborexant-matched placebo, Zolpidem tartrate, Zolpidem-matched placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 1,006 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 60
States / cities: Jasper, Alabama • Glendale, Arizona • Little Rock, Arkansas + 49 more

Conditions: Sleep Disorders, Stress Disorders, Post-Traumatic
Interventions: Paroxetine, Prazosin, placebo; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Primary Insomnia, Sleep Initiation and Maintenance Disorders
Interventions: eszopiclone 3 mg qHS, General cognitive/behavioral interventions for insomnia; Drug · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Sleep Apnea
Interventions: Not listed
Lead sponsor: Akram Khan; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obstructive Sleep Apnea
Interventions: Ultrasound Exam, Polysomnography; Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sleep Disturbance
Interventions: chilipad; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Sympathetic Activity in Post-injury Outcomes: Impact on Sleep and caRdiovascular Health InvesTigation

Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension

Solriamfetol and CBT-I in Patients With Insomnia Disorder

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

The Effect of Spinal Cord Stimulators on Restless Leg Syndrome

New Mothers Alpha-Stim

Correlation Between CPAP Compliance and Food Intake Timing

Skeletal Effects of Chronic Night Shift

Zaleplon in HIV Patients With Depression

Pharyngeal Anatomy In Obstructive Sleep Apnea With HRM

VR-PMR for Post-Burn Symptoms

Novel Technique for Face Mask Ventilation

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome

Colorado Marijuana Users Health Cohort

IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure

Does the Timing of Insomnia Therapy (CBT-i) Impact the Usage and Compliance of Upper Airway Stimulation (UAS) Treatment of Obstructive Sleep Apnea (OSA)

LinguaFlex Tongue Retractor (LTR) for the Treatment of OSA and Snoring in Adults

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

Comparison Of The Berlin Questionnaire To The Portland Sleep Quiz

Ultrasound Against Obstructive Sleep Apnea

Reports on Sleep Quality and Thermoregulation Among Veterans